DeuteRx, LLC
Industry
- Pharmaceuticals
- Vaccines
- Specialty Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Neuromity Therapeutics
See more in Biomedtracker
Latest on DeuteRx, LLC
Scrip
• By Joseph Haas and Dexter Jie Yan
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. The January J.P. Morgan Healthcare Conf
Scrip
• By John Davis
France's metabolic diseases company Poxel SA has licensed a difficult-to-make single-isomer candidate drug, DRX-065, from US firm DeuteRx LLC , which has potential in the treatment of non-alcoholic
Scrip
IN VITRO DIAGNOSTICS 23andMe Inc. 23andMe completes $115mm Series E financing New backer Fidelity Management & Research Co. led a $115mm Series E financing for 23andMe Inc. , which sells DNA te